Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Director comp.

Quince Therapeutics, Inc. (CRTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2023 4 Thye Dirk (CEO) has filed a Form 4 on Quince Therapeutics, Inc.
Txns: Bought 88,000 shares @ $1.26, valued at $110.9k
08/09/2023 4 Thye Dirk (CEO) has filed a Form 4 on Quince Therapeutics, Inc.
Txns: Bought 80,000 shares @ $1.24, valued at $99.2k
08/09/2023 4 Hannah Brendan (Chief Business Officer) has filed a Form 4 on Quince Therapeutics, Inc.
Txns: Bought 71,762 shares @ $1.22, valued at $87.5k
08/09/2023 4 McLoughlin Margaret (Director) has filed a Form 4 on Quince Therapeutics, Inc.
Txns: Bought 8,000 shares @ $1.23, valued at $9.8k
05/26/2023 4 Senner Christopher J. (Director) has filed a Form 4 on Quince Therapeutics, Inc.
Txns: Granted 27,000 options to buy @ $1.58, valued at $42.7k
05/26/2023 4 RYAN UNA S (Director) has filed a Form 4 on Quince Therapeutics, Inc.
Txns: Granted 27,000 options to buy @ $1.58, valued at $42.7k
05/26/2023 4 McLoughlin Margaret (Director) has filed a Form 4 on Quince Therapeutics, Inc.
Txns: Granted 27,000 options to buy @ $1.58, valued at $42.7k
05/26/2023 4 Lamond David (Director) has filed a Form 4 on Quince Therapeutics, Inc.
Txns: Granted 27,000 options to buy @ $1.58, valued at $42.7k
05/26/2023 4 Bray June (Director) has filed a Form 4 on Quince Therapeutics, Inc.
Txns: Granted 27,000 options to buy @ $1.58, valued at $42.7k
03/06/2023 4 Monohon Ted (Chief Accounting Officer & VP) has filed a Form 4 on Quince Therapeutics, Inc.
Txns: Sold 1,871 shares @ $0.98, valued at $1.8k
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/07/2022 4 Monohon Ted (Chief Accounting Officer & VP) has filed a Form 4 on Quince Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,640 shares @ $0.72, valued at $1.2k
09/08/2022 4 Monohon Ted (Chief Accounting Officer & VP) has filed a Form 4 on Quince Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,520 shares @ $1.64, valued at $2.5k
07/01/2022 4 Monohon Ted (Chief Accounting Officer & VP) has filed a Form 4 on Cortexyme, Inc.
Txns: Granted 250,000 options to buy @ $2.26, valued at $565k
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Lamond David (Director) has filed a Form 4 on Cortexyme, Inc.
Txns: Granted 27,000 options to buy @ $3.23, valued at $87.2k
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2022 4 Monohon Ted (Chief Accounting Officer & VP) has filed a Form 4 on Cortexyme, Inc.
Txns: Paid exercise price by delivering 1,529 shares @ $3.12, valued at $4.8k
06/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2022 4 McDowell Caryn Gordon (Chief Legal & Adm. Officer) has filed a Form 4 on Cortexyme, Inc.
Txns: Paid exercise price by delivering 6,700 shares @ $2.8632, valued at $19.2k
Sold 10,800 shares @ $2.8632, valued at $30.9k
05/27/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
05/27/2022 4/A Thye Dirk (CEO) has filed a Form 4 on Cortexyme, Inc.
Txns: Granted 216,322 shares @ $0
05/27/2022 4/A Hannah Brendan (Chief Business Officer) has filed a Form 4 on Cortexyme, Inc.
Txns: Granted 113,569 shares @ $0
05/23/2022 4 Thye Dirk (CEO) has filed a Form 4 on Cortexyme, Inc.
Txns: Granted 64,589 shares @ $0
Granted 206,391 options to buy @ $0.55, valued at $113.5k
Granted 1,979,650 options to buy @ $2.98, valued at $5.9M
05/23/2022 3 Thye Dirk (CEO) has filed a Form 3 on Cortexyme, Inc.
05/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/23/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy